These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10648727)

  • 41. Effects of acute and chronic administration of olanzapine in comparison to clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons in the rat brain.
    Timmerman W; Heijmen M; Westerink BH; Bruggeman R; den Boer JA
    Psychopharmacology (Berl); 1999 Jun; 144(3):286-94. PubMed ID: 10435397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clozapine, SCH 23390 and alpha-flupenthixol but not haloperidol attenuate acute phencyclidine-induced disruption of conditional discrimination performance.
    Dunn MJ; Killcross S
    Psychopharmacology (Berl); 2007 Mar; 190(4):403-14. PubMed ID: 17237918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: an in vivo microdialysis study.
    Jaskiw GE; Collins KA; Pehek EA; Yamamoto BK
    Neuropsychopharmacology; 2001 Jul; 25(1):149-56. PubMed ID: 11377928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.
    den Boon FS; Body S; Hampson CL; Bradshaw CM; Szabadi E; de Bruin N
    J Psychopharmacol; 2012 Sep; 26(9):1231-43. PubMed ID: 21969105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm.
    Carvey PM; Nath ST; Kao LC; Zhang TJ; Lin DH; Singh R; Amdur RL; Klawans HL
    Eur J Pharmacol; 1990 Aug; 184(1):43-53. PubMed ID: 2209714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effects of the adenosine A₂A agonist CGS-21680 and haloperidol on food-reinforced fixed ratio responding in the rat.
    Jones-Cage C; Stratford TR; Wirtshafter D
    Psychopharmacology (Berl); 2012 Mar; 220(1):205-13. PubMed ID: 21898173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage.
    Lipska BK; Weinberger DR
    Neuropsychopharmacology; 1994 May; 10(3):199-205. PubMed ID: 7916917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine dynamics during emotional cognitive processing: Implications of the specific actions of clozapine compared with haloperidol.
    Kawano M; Oshibuchi H; Kawano T; Muraoka H; Tsutsumi T; Yamada M; Inada K; Ishigooka J
    Eur J Pharmacol; 2016 Jun; 781():148-56. PubMed ID: 27085900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
    Sayers AC; Bürki HR; Ruch W; Asper H
    Psychopharmacologia; 1975; 41(2):97-104. PubMed ID: 1171492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms.
    Prus AJ; Baker LE; Meltzer HY
    Pharmacol Biochem Behav; 2004 Feb; 77(2):199-208. PubMed ID: 14751446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C; Morgenstern R; Fink H; Ott T
    Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
    Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons.
    Chiodo LA; Bunney BS
    J Neurosci; 1985 Sep; 5(9):2539-44. PubMed ID: 2863337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behavioral, anti-dopaminergic, and prohypnotic effects of neuroleptics during and after prolonged treatment.
    Biazzi A; Fregnan GB
    Adv Biochem Psychopharmacol; 1980; 24():351-7. PubMed ID: 6105785
    [No Abstract]   [Full Text] [Related]  

  • 58. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations.
    Yamamoto BK; Cooperman MA
    J Neurosci; 1994 Jul; 14(7):4159-66. PubMed ID: 7913120
    [TBL] [Abstract][Full Text] [Related]  

  • 59. One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists.
    Jiang LH; Kasser RJ; Altar CA; Wang RY
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1198-205. PubMed ID: 1972751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
    Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.